KMT2C and cancer: Specifically, KMT2C, a member of the KMT2 family genes, also referred to as myeloid/lymphoid or mixed lineage leukemia protein 3, has been identified as highly expressed in various cancers such as acute myeloid leukemia, low-grade glioma, and thymoma8.